IGF-1, secreted by the liver and by CAFs, activates the RAS/MAPK and PI3K/AKT signaling pathways by binding to the IGF-1R, thereby promoting tumor cell invasion and metastasis (204). The gene discussed is IGF1R; the disease is neoplasm.